SCHEMBL30757281

SCHEMBL30757281

Cn1c(Cl)nc2ccc(Br)cc2c1=O

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.51
KMT2A Q03164 4/20 0.51
CASP3 P42574 3/20 0.49
AVPR1A P37288 1/20 0.48
ATM Q13315 2/20 0.48
HTT P42858 3/20 0.45
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
MAPT P10636 3/20 0.43
RAB9A P51151 2/20 0.43
NT5E P21589 1/20 0.43
PDE7A Q13946 1/20 0.42
NPC1 O15118 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
NLRP3 Q96P20 1/20 0.41
DHODH Q02127 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26688703 1.00 MEN1 (0.51) MEN1KMT2ACASP3AVPR1AATM
SCHEMBL13967321 0.87 RAB9A (0.42) MEN1KMT2ACASP3HTTRXFP1
SCHEMBL9919073 0.82 CASP3 (0.54) MEN1KMT2ACASP3AVPR1AATM
SCHEMBL31240990 0.81 CACNA2D1 (0.47) MEN1KMT2ACASP3AVPR1AATM
SCHEMBL5712376 0.81 SMN1; SMN2 (0.40) MEN1KMT2AHTTRXFP1MAPT
SCHEMBL3820085 0.78 USP2 (0.47) MEN1KMT2ACASP3ATMHTT
SCHEMBL4207211 0.78 PDE7A (0.58) MEN1KMT2ACASP3AVPR1AATM
SCHEMBL3821246 0.77 CASP3 (0.46) MEN1KMT2ACASP3AVPR1AATM
SCHEMBL9954421 0.77 MEN1 (0.51) MEN1KMT2AAVPR1AATMRXFP1
SCHEMBL17674019 0.76 SMN1; SMN2 (0.58) MEN1KMT2ACASP3HTTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4526304-A1 INHIBITORS OF PARG 858 Therapeutics, Inc. (US) 2025-03-26 EP disclosed
WO-2023224998-A1 INHIBITORS OF PARG 858 THERAPEUTICS, INC. (US) 2023-11-23 WO disclosed